{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06493604",
            "orgStudyIdInfo": {
                "id": "ADX-102-DED-032"
            },
            "organization": {
                "fullName": "Aldeyra Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease",
            "officialTitle": "A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-trial-to-assess-the-safety-and-efficacy-of-subjects-with-dry-eye-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-02",
            "studyFirstSubmitQcDate": "2024-07-02",
            "studyFirstPostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Aldeyra Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease",
            "detailedDescription": "Dry eye chamber challenge trial"
        },
        "conditionsModule": {
            "conditions": [
                "Dry Eye Disease"
            ],
            "keywords": [
                "reproxalap"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 110,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Reproxalap Ophthalmic Solution (0.25%) administered six times over two consecutive days",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Reproxalap Ophthalmic Solution (0.25%)"
                    ]
                },
                {
                    "label": "Vehicle Ophthalmic Solution administered six times over two consecutive days",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Vehicle Ophthalmic Solution"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Reproxalap Ophthalmic Solution (0.25%)",
                    "description": "Reproxalap Ophthalmic Solution (0.25%) administered six times over two consecutive days",
                    "armGroupLabels": [
                        "Reproxalap Ophthalmic Solution (0.25%) administered six times over two consecutive days"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Vehicle Ophthalmic Solution",
                    "description": "Vehicle Ophthalmic Solution administered six times over two consecutive days",
                    "armGroupLabels": [
                        "Vehicle Ophthalmic Solution administered six times over two consecutive days"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ocular discomfort symptom score over 100 minutes in the dry eye chamber at Visit 1 and Visit 3",
                    "description": "Measured using a 0 - 100 visual analog scale (VAS) where 0 is \"no discomfort\" and 100 is \"maximal discomfort\"",
                    "timeFrame": "Day -14 to Day 2"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years of age (either gender and any race)\n* Ability to provide written informed consent and sign the Health Information Portability and Accountability Act form\n* Reported history of ocular discomfort associated with dry eye disease for at least 6 months prior to Visit 1\n* Reported history of use or desire to use eye drops for dry eye symptoms within 6 months of Visit 1\n\nExclusion Criteria:\n\n* Clinically significant slit lamp findings at Visit 1 that may include active blepharitis, meibomian gland dysfunction, lid margin inflammation, or active ocular allergies that require therapeutic treatment, and/or in the opinion of the investigator may interfere with study parameters\n* Diagnosis of an ongoing ocular infection (bacterial, viral, or fungal), or active ocular inflammation at Visit 1\n* Contact lens use within 7 days of Visit 1 or anticipated use of contact lenses during the trial\n* Previous laser-assisted in situ keratomileusis surgery within the last 12 months\n* Systemic corticosteroid or other immunomodulator therapy (not including inhaled corticosteroids) within 14 days of Visit 1, or any planned immunomodulatory therapy throughout the clinical trial\n* Use of and unwillingness to discontinue topical ophthalmic prescriptions (including medications for glaucoma) or over-the-counter solutions (not including artificial tears), gels, or scrubs for the duration of the trial (excluding medications allowed for the conduct of the trial)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Bill Cavanagh",
                    "role": "CONTACT",
                    "phone": "(781) 761-4904",
                    "email": "bcavanagh@aldeyra.com"
                }
            ],
            "locations": [
                {
                    "facility": "Andover Eye Associates",
                    "status": "RECRUITING",
                    "city": "Andover",
                    "state": "Massachusetts",
                    "zip": "01810",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gail L Torkildsen, MD",
                            "role": "CONTACT",
                            "phone": "978-475-0705"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.65843,
                        "lon": -71.137
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015352",
                    "term": "Dry Eye Syndromes"
                },
                {
                    "id": "D000007638",
                    "term": "Keratoconjunctivitis Sicca"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007766",
                    "term": "Lacrimal Apparatus Diseases"
                },
                {
                    "id": "D000007637",
                    "term": "Keratoconjunctivitis"
                },
                {
                    "id": "D000003231",
                    "term": "Conjunctivitis"
                },
                {
                    "id": "D000003229",
                    "term": "Conjunctival Diseases"
                },
                {
                    "id": "D000007634",
                    "term": "Keratitis"
                },
                {
                    "id": "D000003316",
                    "term": "Corneal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18040",
                    "name": "Dry Eye Syndromes",
                    "asFound": "Dry Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10664",
                    "name": "Keratoconjunctivitis Sicca",
                    "asFound": "Dry Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "asFound": "Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10663",
                    "name": "Keratoconjunctivitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10786",
                    "name": "Lacrimal Apparatus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6455",
                    "name": "Conjunctivitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6453",
                    "name": "Conjunctival Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10660",
                    "name": "Keratitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6539",
                    "name": "Corneal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "asFound": "Procedure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Anxiety",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}